Title of Collaborative Activity: |
Evaluation of the safety, tolerability, pharmacokinetics, and pharmacodynamics of long-term mitapivat dosing in subjects with stable sickle cell disease |
Description of Collaborative Activity: |
Evaluation of the safety, tolerability, pharmacokinetics, and pharmacodynamics of long-term mitapivat dosing in subjects with stable sickle cell disease |
Type of Collaborative Activity: |
Research Initiative
|
Year the Collaborative Activity Originated: |
|
NIH Participating Institutes/Centers/Office of the Director: |
NHLBI |
HHS Agency Collaborators on this Activity: |
FDA |
